(Summary) (Company) (Chart)
4 September 2017 Price $16.80 1yr Target $14.20 Analysts 5 Dividend $0.00 Payout Ratio 0.00% 1yr Cap Gain -15.48% Yield 0.00% 1yr Tot Return -15.48% P/E 84.00 PEG 1.15 Beta 2.06 | EPS (ttm) $0.20 EPS next yr $0.69 Forward P/E 24.42 EPS next 5yr 73.20% 1yr Price Support $50.50 Market Cap $1.96 Bil Revenues $108.70 Mil Earnings $24.20 Mil Profit Margin % Quick Ratio 3.80 Current Ratio 4.00 Debt/Equity 0.07 | 1yr RevGR 61.71% 3yr RevGR 97.39% 5yr RevGR --- 1yr EarnGR --- 3yr EarnGR --- 5yr EarnGR --- 1yr DivGR --- 3yr DivGR --- 5yr DivGR --- ROA 33.00% ROE 51.40% |
My Path Forward
I started buying these shares near $10 per share with the intent of making a quick 20% gain. I've been adding more shares since then despite the fact that it continues to rise well past my initial estimate. This appears to be a very strong high growth stock in a sector that is exploding. I intend to continue to add shares in this company as well as other biotech companies in the near future. I believe we are on the cusp os a biotech revolution that will continue for decades. I intend to own shares of those companies that appear to be at the forefront of upcoming technologies. This company appears to be one of them.